Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies, 65865-65867 [E8-26466]

Download as PDF Federal Register / Vol. 73, No. 215 / Wednesday, November 5, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings hsrobinson on PROD1PC76 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Organ Transplantation Program Projects. Date: December 3, 2008. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Carol J. Goter-Robinson, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7791, goterrobinsonc@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, HIV-Associated Nephropathy. Date: December 11, 2008. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Lakshmanan Sankaran, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7799, ls38z@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) VerDate Aug<31>2005 17:24 Nov 04, 2008 Jkt 217001 Dated: October 28, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–26339 Filed 11–4–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: SUMMARY: The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644). A notice listing all currently certified laboratories is published in the Federal Register during the first week of each month. If any laboratory’s certification is suspended or revoked, the laboratory will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end, and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http:// www.workplace.samhsa.gov and http:// www.drugfreeworkplace.gov. FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 2– 1042, One Choke Cherry Road, Rockville, Maryland 20857; 240–276– 2600 (voice), 240–276–2610 (fax). SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in accordance with Executive Order 12564 and section 503 of Public Law 100–71. Subpart C of the Mandatory Guidelines, ‘‘Certification of Laboratories Engaged in Urine Drug PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 65865 Testing for Federal Agencies,’’ sets strict standards that laboratories must meet in order to conduct drug and specimen validity tests on urine specimens for Federal agencies. To become certified, an applicant laboratory must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories which claim to be in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A laboratory must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA) which attests that it has met minimum standards. In accordance with Subpart C of the Mandatory Guidelines dated April 13, 2004 (69 FR 19644), the following laboratories meet the minimum standards to conduct drug and specimen validity tests on urine specimens: ACL Laboratories 8901 W. Lincoln Ave. West Allis, WI 53227 414–328–7840/800–877–7016 (Formerly: Bayshore Clinical Laboratory) ACM Medical Laboratory, Inc. 160 Elmgrove Park Rochester, NY 14624 585–429–2264 Advanced Toxicology Network 3560 Air Center Cove, Suite 101 Memphis, TN 38118 901–794–5770/888–290–1150 Aegis Sciences Corporation 345 Hill Ave. Nashville, TN 37210 615–255–2400 (Formerly: Aegis Analytical Laboratories, Inc.) Baptist Medical Center-Toxicology Laboratory 9601 I–630, Exit 7 Little Rock, AR 72205–7299 501–202–2783 (Formerly: Forensic Toxicology Laboratory Baptist Medical Center) Clinical Reference Lab 8433 Quivira Road Lenexa, KS 66215–2802 800–445–6917 Diagnostic Services, Inc., dba DSI 12700 Westlinks Drive Fort Myers, FL 33913 239–561–8200/800–735–5416 Doctors Laboratory, Inc. 2906 Julia Drive Valdosta, GA 31602 229–671–2281 DrugScan, Inc. E:\FR\FM\05NON1.SGM 05NON1 hsrobinson on PROD1PC76 with NOTICES 65866 Federal Register / Vol. 73, No. 215 / Wednesday, November 5, 2008 / Notices P.O. Box 2969 1119 Mearns Road Warminster, PA 18974 215–674–9310 DynaLIFE Dx * 10150–102 St., Suite 200 Edmonton, Alberta Canada T5J 5E2 780–451–3702/800–661–9876 (Formerly: Dynacare Kasper Medical Laboratories) ElSohly Laboratories, Inc. 5 Industrial Park Drive Oxford, MS 38655 662–236–2609 Gamma-Dynacare Medical Laboratories* A Division of the Gamma-Dynacare Laboratory Partnership 245 Pall Mall Street London, ONT, Canada N6A 1P4 519–679–1630 Kroll Laboratory Specialists, Inc. 1111 Newton St. Gretna, LA 70053 504–361–8989/800–433–3823 (Formerly: Laboratory Specialists, Inc.) Kroll Laboratory Specialists, Inc. 450 Southlake Blvd. Richmond, VA 23236 804–378–9130 (Formerly: Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.) Laboratory Corporation of America Holdings 7207 N. Gessner Road Houston, TX 77040 713–856–8288/800–800–2387 Laboratory Corporation of America Holdings 69 First Ave. Raritan, NJ 08869 908–526–2400/800–437–4986 (Formerly: Roche Biomedical Laboratories, Inc.) Laboratory Corporation of America Holdings 1904 Alexander Drive Research Triangle Park, NC 27709 919–572–6900/800–833–3984 (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group) Laboratory Corporation of America Holdings 1120 Main Street Southaven, MS 38671 866–827–8042/800–233–6339 (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/ National Laboratory Center) LabOne, Inc. d/b/a Quest Diagnostics 10101 Renner Blvd. VerDate Aug<31>2005 17:24 Nov 04, 2008 Jkt 217001 Lenexa, KS 66219 913–888–3927/800–873–8845 (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.) Maxxam Analytics* 6740 Campobello Road Mississauga, ON Canada L5N 2L8 905–817–5700 (Formerly: Maxxam Analytics Inc., NOVAMANN (Ontario), Inc.) MedTox Laboratories, Inc. 402 W. County Road D St. Paul, MN 55112 651–636–7466/800–832–3244 MetroLab-Legacy Laboratory Services 1225 NE 2nd Ave. Portland, OR 97232 503–413–5295/800–950–5295 Minneapolis Veterans Affairs Medical Center Forensic Toxicology Laboratory 1 Veterans Drive Minneapolis, MN 55417 612–725–2088 National Toxicology Laboratories, Inc. 1100 California Ave. Bakersfield, CA 93304 661–322–4250/800–350–3515 One Source Toxicology Laboratory, Inc. 1213 Genoa-Red Bluff Pasadena, TX 77504 888–747–3774 (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory) Oregon Medical Laboratories 123 International Way Springfield, OR 97477 541–341–8092 Pacific Toxicology Laboratories 9348 DeSoto Ave. Chatsworth, CA 91311 800–328–6942 (Formerly: Centinela Hospital Airport Toxicology Laboratory) Pathology Associates Medical Laboratories 110 West Cliff Dr. Spokane, WA 99204 509–755–8991 / 800–541–7891x7 Pharmatech, Inc. 10151 Barnes Canyon Road San Diego, CA 92121 858–643–5555 Quest Diagnostics Incorporated 3175 Presidential Dr. Atlanta, GA 30340 770–452–1590 / 800–729–6432 (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline BioScience Laboratories) Quest Diagnostics Incorporated PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 400 Egypt Road Norristown, PA 19403 610–631–4600 / 877–642–2216 (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline BioScience Laboratories) Quest Diagnostics Incorporated 7600 Tyrone Ave. Van Nuys, CA 91405 866–370–6699 / 818–989–2521 (Formerly: SmithKline Beecham Clinical Laboratories) S.E.D. Medical Laboratories 5601 Office Blvd. Albuquerque, NM 87109 505–727–6300 / 800–999–5227 South Bend Medical Foundation, Inc. 530 N. Lafayette Blvd. South Bend, IN 46601 574–234–4176 x276 Southwest Laboratories 4645 E. Cotton Center Boulevard Suite 177 Phoenix, AZ 85040 602–438–8507 / 800–279–0027 Sparrow Health System Toxicology Testing Center, St. Lawrence Campus 1210 W. Saginaw Lansing, MI 48915 517–364–7400 (Formerly: St. Lawrence Hospital & Healthcare System) St. Anthony Hospital Toxicology Laboratory 1000 N. Lee St. Oklahoma City, OK 73101 405–272–7052 Toxicology & Drug Monitoring Laboratory University of Missouri Hospital & Clinics 301 Business Loop 70 West, Suite 208 Columbia, MO 65203 573–882–1273 Toxicology Testing Service, Inc. 5426 N.W. 79th Ave. Miami, FL 33166 305–593–2260 US Army Forensic Toxicology Drug Testing Laboratory 2490 Wilson St. Fort George G. Meade, MD 20755–5235 301–677–7085 The following laboratory will be voluntarily withdrawing from the National Laboratory Certification Program on November 15, 2008: Laboratory Corporation of America Holdings 550 17th Ave., Suite 300 Seattle, WA 98122 206–923–7020 / 800–898–0180 (Formerly: DrugProof, Division of Dynacare/Laboratory of Pathology, LLC; Laboratory of Pathology of Seattle, Inc.; DrugProof, Division of E:\FR\FM\05NON1.SGM 05NON1 Federal Register / Vol. 73, No. 215 / Wednesday, November 5, 2008 / Notices Laboratory of Pathology of Seattle, Inc.) *The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS’ NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on April 13, 2004 (69 FR 19644). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Elaine Parry, Acting Director, Office of Program Services, SAMHSA. [FR Doc. E8–26466 Filed 11–4–08; 8:45 am] BILLING CODE 4160–20–P DEPARTMENT OF HOMELAND SECURITY a major disaster under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121–5207 (the Stafford Act), as follows: I have determined that the damage in certain areas of the State of Florida resulting from Hurricane Gustav during the period of August 31 to September 7, 2008, is of sufficient severity and magnitude to warrant a major disaster declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121–5207 (the Stafford Act). Therefore, I declare that such a major disaster exists in the State of Florida. In order to provide Federal assistance, you are hereby authorized to allocate from funds available for these purposes such amounts as you find necessary for Federal disaster assistance and administrative expenses. You are authorized to provide Public Assistance in the designated areas, Hazard Mitigation throughout the State, and any other forms of assistance under the Stafford Act that you deem appropriate. Consistent with the requirement that Federal assistance be supplemental, any Federal funds provided under the Stafford Act for Hazard Mitigation will be limited to 75 percent of the total eligible costs. Federal funds provided under the Stafford Act for Public Assistance also will be limited to 75 percent of the total eligible costs, except for any particular projects that are eligible for a higher Federal cost-sharing percentage under the FEMA Public Assistance Pilot Program instituted pursuant to 6 U.S.C. 777. If Other Needs Assistance under Section 408 of the Stafford Act is later requested and warranted, Federal funding under that program also will be limited to 75 percent of the total eligible costs. Further, you are authorized to make changes to this declaration to the extent allowable under the Stafford Act. Federal Emergency Management Agency, DHS. ACTION: Notice. The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Administrator, under Executive Order 12148, as amended, Jeffery L. Bryant, of FEMA is appointed to act as the Federal Coordinating Officer for this declared disaster. The following areas of the State of Florida have been designated as adversely affected by this declared major disaster: SUMMARY: This is a notice of the Presidential declaration of a major disaster for the State of Florida (FEMA– 1806–DR), dated October 27, 2008, and related determinations. DATES: Effective Date: October 27, 2008. FOR FURTHER INFORMATION CONTACT: Peggy Miller, Disaster Assistance Directorate, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646–3886. SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter dated October 27, 2008, the President declared Bay, Escambia, Franklin, Gulf, Okaloosa, and Santa Rosa Counties for Public Assistance. All counties within the State of Florida are eligible to apply for assistance under the Hazard Mitigation Grant Program. The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households In Presidentially Federal Emergency Management Agency [FEMA–1806–DR] Florida; Major Disaster and Related Determinations hsrobinson on PROD1PC76 with NOTICES AGENCY: VerDate Aug<31>2005 17:24 Nov 04, 2008 Jkt 217001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 65867 Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance— Disaster Housing Operations for Individuals and Households; 97.050, Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant. R. David Paulison, Administrator, Federal Emergency Management Agency. [FR Doc. E8–26298 Filed 11–4–08; 8:45 am] BILLING CODE 9111–23–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [FEMA–1805–DR] Ohio; Major Disaster and Related Determinations Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: SUMMARY: This is a notice of the Presidential declaration of a major disaster for the State of Ohio (FEMA– 1805–DR), dated October 24, 2008, and related determinations. DATES: Effective Date: October 24, 2008. FOR FURTHER INFORMATION CONTACT: Peggy Miller, Disaster Assistance Directorate, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646–3886. SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter dated October 24, 2008, the President declared a major disaster under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121–5207 (the Stafford Act), as follows: I have determined that the damage in certain areas of the State of Ohio resulting from a severe wind storm associated with Tropical Depression Ike on September 14, 2008, is of sufficient severity and magnitude to warrant a major disaster declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121– 5207 (the Stafford Act). Therefore, I declare that such a major disaster exists in the State of Ohio. In order to provide Federal assistance, you are hereby authorized to allocate from funds available for these purposes such amounts as you find necessary for Federal disaster assistance and administrative expenses. You are authorized to provide Public Assistance in the designated areas, Hazard Mitigation throughout the State, and any other forms of assistance under the Stafford Act that you deem appropriate. Consistent E:\FR\FM\05NON1.SGM 05NON1

Agencies

[Federal Register Volume 73, Number 215 (Wednesday, November 5, 2008)]
[Notices]
[Pages 65865-65867]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26466]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Current List of Laboratories Which Meet Minimum Standards To 
Engage in Urine Drug Testing for Federal Agencies

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) notifies 
Federal agencies of the laboratories currently certified to meet the 
standards of Subpart C of the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory 
Guidelines were first published in the Federal Register on April 11, 
1988 (53 FR 11970), and subsequently revised in the Federal Register on 
June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on 
April 13, 2004 (69 FR 19644).
    A notice listing all currently certified laboratories is published 
in the Federal Register during the first week of each month. If any 
laboratory's certification is suspended or revoked, the laboratory will 
be omitted from subsequent lists until such time as it is restored to 
full certification under the Mandatory Guidelines.
    If any laboratory has withdrawn from the HHS National Laboratory 
Certification Program (NLCP) during the past month, it will be listed 
at the end, and will be omitted from the monthly listing thereafter.
    This notice is also available on the Internet at http://
www.workplace.samhsa.gov and http://www.drugfreeworkplace.gov.

FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh, Division of 
Workplace Programs, SAMHSA/CSAP, Room 2-1042, One Choke Cherry Road, 
Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax).

SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in 
accordance with Executive Order 12564 and section 503 of Public Law 
100-71. Subpart C of the Mandatory Guidelines, ``Certification of 
Laboratories Engaged in Urine Drug Testing for Federal Agencies,'' sets 
strict standards that laboratories must meet in order to conduct drug 
and specimen validity tests on urine specimens for Federal agencies. To 
become certified, an applicant laboratory must undergo three rounds of 
performance testing plus an on-site inspection. To maintain that 
certification, a laboratory must participate in a quarterly performance 
testing program plus undergo periodic, on-site inspections.
    Laboratories which claim to be in the applicant stage of 
certification are not to be considered as meeting the minimum 
requirements described in the HHS Mandatory Guidelines. A laboratory 
must have its letter of certification from HHS/SAMHSA (formerly: HHS/
NIDA) which attests that it has met minimum standards.
    In accordance with Subpart C of the Mandatory Guidelines dated 
April 13, 2004 (69 FR 19644), the following laboratories meet the 
minimum standards to conduct drug and specimen validity tests on urine 
specimens:

ACL Laboratories
8901 W. Lincoln Ave.
West Allis, WI 53227
414-328-7840/800-877-7016
(Formerly: Bayshore Clinical Laboratory)

ACM Medical Laboratory, Inc.
160 Elmgrove Park
Rochester, NY 14624
585-429-2264

Advanced Toxicology Network
3560 Air Center Cove, Suite 101
Memphis, TN 38118
901-794-5770/888-290-1150

Aegis Sciences Corporation
345 Hill Ave.
Nashville, TN 37210
615-255-2400
(Formerly: Aegis Analytical Laboratories, Inc.)

Baptist Medical Center-Toxicology Laboratory
9601 I-630, Exit 7
Little Rock, AR 72205-7299
501-202-2783
(Formerly: Forensic Toxicology Laboratory Baptist Medical Center)

Clinical Reference Lab
8433 Quivira Road
Lenexa, KS 66215-2802
800-445-6917

Diagnostic Services, Inc., dba DSI
12700 Westlinks Drive
Fort Myers, FL 33913
239-561-8200/800-735-5416

Doctors Laboratory, Inc.
2906 Julia Drive
Valdosta, GA 31602
229-671-2281

DrugScan, Inc.

[[Page 65866]]

P.O. Box 2969
1119 Mearns Road
Warminster, PA 18974
215-674-9310

DynaLIFE Dx *
10150-102 St., Suite 200
Edmonton, Alberta
Canada T5J 5E2
780-451-3702/800-661-9876
(Formerly: Dynacare Kasper Medical Laboratories)

ElSohly Laboratories, Inc.
5 Industrial Park Drive
Oxford, MS 38655
662-236-2609

Gamma-Dynacare Medical Laboratories*
A Division of the Gamma-Dynacare Laboratory Partnership
245 Pall Mall Street
London, ONT, Canada N6A 1P4
519-679-1630

Kroll Laboratory Specialists, Inc.
1111 Newton St.
Gretna, LA 70053
504-361-8989/800-433-3823
(Formerly: Laboratory Specialists, Inc.)

Kroll Laboratory Specialists, Inc.
450 Southlake Blvd.
Richmond, VA 23236
804-378-9130
(Formerly: Scientific Testing Laboratories, Inc.; Kroll Scientific 
Testing Laboratories, Inc.)

Laboratory Corporation of America Holdings
7207 N. Gessner Road
Houston, TX 77040
713-856-8288/800-800-2387

Laboratory Corporation of America Holdings
69 First Ave.
Raritan, NJ 08869
908-526-2400/800-437-4986
(Formerly: Roche Biomedical Laboratories, Inc.)

Laboratory Corporation of America Holdings
1904 Alexander Drive
Research Triangle Park, NC 27709
919-572-6900/800-833-3984
(Formerly: LabCorp Occupational Testing Services, Inc., CompuChem 
Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche 
Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of 
the Roche Group)

Laboratory Corporation of America Holdings
1120 Main Street
Southaven, MS 38671
866-827-8042/800-233-6339
(Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/
National Laboratory Center)

LabOne, Inc. d/b/a Quest Diagnostics
10101 Renner Blvd.
Lenexa, KS 66219
913-888-3927/800-873-8845
(Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for 
Laboratory Services, a Division of LabOne, Inc.)

Maxxam Analytics*
6740 Campobello Road
Mississauga, ON
Canada L5N 2L8
905-817-5700
(Formerly: Maxxam Analytics Inc., NOVAMANN (Ontario), Inc.)

MedTox Laboratories, Inc.
402 W. County Road D
St. Paul, MN 55112
651-636-7466/800-832-3244

MetroLab-Legacy Laboratory Services
1225 NE 2nd Ave.
Portland, OR 97232
503-413-5295/800-950-5295

Minneapolis Veterans Affairs Medical Center
Forensic Toxicology Laboratory
1 Veterans Drive
Minneapolis, MN 55417
612-725-2088

National Toxicology Laboratories, Inc.
1100 California Ave.
Bakersfield, CA 93304
661-322-4250/800-350-3515

One Source Toxicology Laboratory, Inc.
1213 Genoa-Red Bluff
Pasadena, TX 77504
888-747-3774
(Formerly: University of Texas Medical Branch, Clinical Chemistry 
Division; UTMB Pathology-Toxicology Laboratory)

Oregon Medical Laboratories
123 International Way
Springfield, OR 97477
541-341-8092

Pacific Toxicology Laboratories
9348 DeSoto Ave.
Chatsworth, CA 91311
800-328-6942
(Formerly: Centinela Hospital Airport Toxicology Laboratory)

Pathology Associates Medical Laboratories
110 West Cliff Dr.
Spokane, WA 99204
509-755-8991 / 800-541-7891x7

Pharmatech, Inc.
10151 Barnes Canyon Road
San Diego, CA 92121
858-643-5555

Quest Diagnostics Incorporated
3175 Presidential Dr.
Atlanta, GA 30340
770-452-1590 / 800-729-6432
(Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-
Science Laboratories)

Quest Diagnostics Incorporated
400 Egypt Road
Norristown, PA 19403
610-631-4600 / 877-642-2216
(Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-
Science Laboratories)

Quest Diagnostics Incorporated
7600 Tyrone Ave.
Van Nuys, CA 91405
866-370-6699 / 818-989-2521
(Formerly: SmithKline Beecham Clinical Laboratories)

S.E.D. Medical Laboratories
5601 Office Blvd.
Albuquerque, NM 87109
505-727-6300 / 800-999-5227

South Bend Medical Foundation, Inc.
530 N. Lafayette Blvd.
South Bend, IN 46601
574-234-4176 x276

Southwest Laboratories
4645 E. Cotton Center Boulevard
Suite 177
Phoenix, AZ 85040
602-438-8507 / 800-279-0027

Sparrow Health System
Toxicology Testing Center, St. Lawrence Campus
1210 W. Saginaw
Lansing, MI 48915
517-364-7400
(Formerly: St. Lawrence Hospital & Healthcare System)

St. Anthony Hospital Toxicology Laboratory
1000 N. Lee St.
Oklahoma City, OK 73101
405-272-7052

Toxicology & Drug Monitoring Laboratory
University of Missouri Hospital & Clinics
301 Business Loop 70 West, Suite 208
Columbia, MO 65203
573-882-1273

Toxicology Testing Service, Inc.
5426 N.W. 79th Ave.
Miami, FL 33166
305-593-2260

US Army Forensic Toxicology Drug Testing Laboratory
2490 Wilson St.
Fort George G. Meade, MD 20755-5235
301-677-7085
    The following laboratory will be voluntarily withdrawing from the 
National Laboratory Certification Program on November 15, 2008:

Laboratory Corporation of America Holdings
550 17th Ave., Suite 300
Seattle, WA 98122
206-923-7020 / 800-898-0180
(Formerly: DrugProof, Division of Dynacare/Laboratory of Pathology, 
LLC; Laboratory of Pathology of Seattle, Inc.; DrugProof, Division of

[[Page 65867]]

Laboratory of Pathology of Seattle, Inc.)

    *The Standards Council of Canada (SCC) voted to end its 
Laboratory Accreditation Program for Substance Abuse (LAPSA) 
effective May 12, 1998. Laboratories certified through that program 
were accredited to conduct forensic urine drug testing as required 
by U.S. Department of Transportation (DOT) regulations. As of that 
date, the certification of those accredited Canadian laboratories 
will continue under DOT authority. The responsibility for conducting 
quarterly performance testing plus periodic on-site inspections of 
those LAPSA-accredited laboratories was transferred to the U.S. HHS, 
with the HHS' NLCP contractor continuing to have an active role in 
the performance testing and laboratory inspection processes. Other 
Canadian laboratories wishing to be considered for the NLCP may 
apply directly to the NLCP contractor just as U.S. laboratories do.
    Upon finding a Canadian laboratory to be qualified, HHS will 
recommend that DOT certify the laboratory (Federal Register, July 
16, 1996) as meeting the minimum standards of the Mandatory 
Guidelines published in the Federal Register on April 13, 2004 (69 
FR 19644). After receiving DOT certification, the laboratory will be 
included in the monthly list of HHS-certified laboratories and 
participate in the NLCP certification maintenance program.

Elaine Parry,
Acting Director, Office of Program Services, SAMHSA.
 [FR Doc. E8-26466 Filed 11-4-08; 8:45 am]
BILLING CODE 4160-20-P